Literature DB >> 1984536

Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study.

D T Felson1, D Sloutskis, J J Anderson, J M Anthony, D P Kiel.   

Abstract

Thiazide diuretics may preserve bone mass and prevent elderly women's osteopenic fractures, but studies have not distinguished between thiazide preparations or examined former users. We performed a case-control study looking at thiazide use and subsequent hip fracture in postmenopausal female members of the Framingham Study cohort. Cases who had experienced a first hip fracture (n = 176) were compared with age-matched controls (n = 672). Results showed a modest protective effect of any recent thiazide use (not significant). However, recent pure thiazide users experienced significant protection against fracture (adjusted odds ratio, 0.31; 95% confidence interval, 0.11 to 0.88), whereas recent users of combination drugs containing thiazides experienced no protection (adjusted odds ratio, 1.16; 95% confidence interval, 0.44 to 3.05). Combination drugs generally contained only 25 mg of hydrochlorothiazide, suggesting that the small amount of thiazide was insufficient to preserve bone mass. Former thiazide users were not protected against fracture. In sum, recent pure thiazide use in women protects against hip fracture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984536

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

1.  Mitogenic action of hydrochlorothiazide on human osteoblasts in vitro: requirement for platelet-derived growth factor.

Authors:  K H Lau; X D Song; M Ochi; J E Wergedal
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

2.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

Review 3.  The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.

Authors:  Joshua I Barzilay; Barry R Davis; Sara L Pressel; Alokananda Ghosh; Rachel Puttnam; Karen L Margolis; Paul K Whelton
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

4.  A prospective study of thiazide use and fractures in women.

Authors:  D Feskanich; W C Willett; M J Stampfer; G A Colditz
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 5.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

6.  A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women.

Authors:  R D Wasnich; J W Davis; Y F He; H Petrovich; P D Ross
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

Review 7.  Can thiazide diuretics be recommended routinely to reduce hip fracture risk?

Authors:  P B Thapa; W A Ray
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

Review 8.  What constitutes evidence for drug efficacy in osteoporosis?

Authors:  J A Kanis
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

9.  Optimal age of commencing and discontinuing thiazide therapy to protect against fractures.

Authors:  C Kruse; P Eiken; P Vestergaard
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

Review 10.  Drug treatment as a cause of falls in old age. A review of the offending agents.

Authors:  A J Campbell
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.